GALAXY AND
COLLABORATIVE PUBLICATIONS
Kim KJ, Wang L, Su YC, Gillespie GY, Salhotra A,
Lal B, Laterra J. Systemic anti-hepatocyte growth factor
monoclonal antibody therapy induces the regression of intracranial glioma
xenografts. Clin Cancer Res 12: 1292-1298,
2006.
Binning MJ, Niazi T, Pedone CA, Lal B,
Eberhart CG, Kim KJ, Laterra J, Fults DW
Hepatocyte growth factor and sonic Hedgehog expression in cerebellar
neural progenitor cells costimulate medulloblastoma initiation and growth. Cancer Res 68: 7838-45, 2008.
Stabile LP, Rothstein ME, Keohavong P, Jin J,
Yin J, Land SR, Dacic S, Luong TM, Kim KJ, Dulak AM, Siegfried JM. Therapeutic targeting of human hepatocyte
growth factor with a single neutralizing monoclonal antibody reduces lung
tumorigenesis. Mol Cancer Ther
7:1913-1922, 2008.
Lal
B, Goodwin CR, Sang Y, Foss CA, Cornet K, Muzamil S, Pomper MG, Kim KJ, Laterra J. EGFRvIII and c-Met pathway inhibitors
synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts. Mol Cancer Ther
8:1751-1760, 2009.
Zhao
W-m, Wang L, Park H, Chhim S, Tanphanich M, Yashiro M, and Kim KJ. Monoclonal antibodies to fibroblast growth
factor receptor 2 effectively inhibit growth of gastric tumor xenografts. Clin
Cancer Res 16:5750-5820, 2010.
Coon V, Laukert T, Pedone CA, Laterra J, Kim KJ, Fults DW. Molecular Therapy Targeting Sonic Hedgehog
and Hepatocyte Growth Factor Signaling in a Mouse Model of Medulloblastoma. Mol Cancer Ther 9:2627-2636, 2010.
Wang, L., Park, H., Chhim, S., Ding, Y., Jiang, W., Queen, C., Kim, K.J. A novel monoclonal antibody
to fibroblast growth factor 2 effectively inhibits growth of hepatocellular
carcinoma xenografts. Mol. Cancer Ther 11: 864-872, 2012.